Zabiciprilat

This classification denotes an ace inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0A2D355316. European Medicines Agency schedules Zabiciprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00126MIG. Zabiciprilat generally arises in the molecular formula C21H28N2O5. The term ZABICIPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, no. 3 1991, list 31.) ZABICIPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zabiciprilat under HS 29333999 and SITC 51574. As of Q4 2014, ZABICIPRILAT remains the US FDA Preferred Term for this commodity. Zabiciprilat bears US NLM identifiers UMLS ID C0165809 and NCI Concept Code C66678. SMILES: OC(=O)C1N(C2CCC1CC2)C(=O)C(NC(CCc1ccccc1)C(=O)O)C.